
Shimadzu (Duisburg, Germany) has announced a collaboration with the University Medical Center Göttingen (UMG) (Germany). The collaboration will focus on the development of new clinical laboratory methods using liquid chromatography–mass spectrometry (LC–MS) for therapeutic drug monitoring (TDM) analysis.
























